Skip to main content
PMC home page
American Journal of Public Health logoLink to American Journal of Public Health
. 1999 Sep;89(9):1315–1318. doi: 10.2105/ajph.89.9.1315

The global burden of mental disorders.

T B Ustün 1
PMCID: PMC1508755  PMID: 10474545

Abstract

Recent data on the burden of mental disorders worldwide demonstrates a major public health problem that affects patients, society, and nations as a whole. Research must be done to find effective ways to deal with the increasing burden of mental disorders. Given the growing evidence that mental disorders are disorders of the brain and that they can be treated effectively with both psychosocial counseling and psychotropic medications, intervention packages could be developed to deal with the increasing burden. Such packages should be tested for real-world effectiveness and their cost-effectiveness should be demonstrated to guide policymakers to choose from among many other non-mental health interventions. The transportability and sustainability of intervention packages should be studied in public health research and a link between efficacy, effectiveness, cost-effectiveness, generalizability, and sustainability should be demonstrated. The World Health Organization's initiative on the World Mental Health 2000 Survey will provide the first basic epidemiologic data. Together with other data, the initiative will provide solid evidence for including mental disorders into essential treatment packages. In this way, parity can be achieved for mental disorders and mental health can be mainstreamed into health and public health practice.

Full text

PDF
1315

Images in this article

1316FIGURE 1
on p.1316

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andreasen N. C. Linking mind and brain in the study of mental illnesses: a project for a scientific psychopathology. Science. 1997 Mar 14;275(5306):1586–1593. doi: 10.1126/science.275.5306.1586. [DOI] [PubMed] [Google Scholar]
  2. Barker D. J. The Wellcome Foundation Lecture, 1994. The fetal origins of adult disease. Proc Biol Sci. 1995 Oct 23;262(1363):37–43. doi: 10.1098/rspb.1995.0173. [DOI] [PubMed] [Google Scholar]
  3. Berman R. M., Narasimhan M., Miller H. L., Anand A., Cappiello A., Oren D. A., Heninger G. R., Charney D. S. Transient depressive relapse induced by catecholamine depletion: potential phenotypic vulnerability marker? Arch Gen Psychiatry. 1999 May;56(5):395–403. doi: 10.1001/archpsyc.56.5.395. [DOI] [PubMed] [Google Scholar]
  4. Bobadilla J. L., Cowley P., Musgrove P., Saxenian H. Design, content and financing of an essential national package of health services. Bull World Health Organ. 1994;72(4):653–662. [PMC free article] [PubMed] [Google Scholar]
  5. Hemingway H., Marmot M. Evidence based cardiology: psychosocial factors in the aetiology and prognosis of coronary heart disease. Systematic review of prospective cohort studies. BMJ. 1999 May 29;318(7196):1460–1467. doi: 10.1136/bmj.318.7196.1460. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Kalache A. Demographic transition poses a challenge to societies worldwide. Trop Med Int Health. 1997 Oct;2(10):925–926. doi: 10.1046/j.1365-3156.1997.d01-162.x. [DOI] [PubMed] [Google Scholar]
  7. Kessler R. C. The World Health Organization International Consortium in Psychiatric Epidemiology (ICPE): initial work and future directions -- the NAPE Lecture 1998. Nordic Association for Psychiatric Epidemiology. Acta Psychiatr Scand. 1999 Jan;99(1):2–9. doi: 10.1111/j.1600-0447.1999.tb05378.x. [DOI] [PubMed] [Google Scholar]
  8. Lehman A. F., Steinwachs D. M. Translating research into practice: the Schizophrenia Patient Outcomes Research Team (PORT) treatment recommendations. Schizophr Bull. 1998;24(1):1–10. doi: 10.1093/oxfordjournals.schbul.a033302. [DOI] [PubMed] [Google Scholar]
  9. Malt U. F., Robak O. H., Madsbu H. P., Bakke O., Loeb M. The Norwegian naturalistic treatment study of depression in general practice (NORDEP)-I: randomised double blind study. BMJ. 1999 May 1;318(7192):1180–1184. doi: 10.1136/bmj.318.7192.1180. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Manton K. G., Stallard E., Corder L. Changes in the age dependence of mortality and disability: cohort and other determinants. Demography. 1997 Feb;34(1):135–157. [PubMed] [Google Scholar]
  11. Mazziotta J. C. Mapping mental illness. A new era. Arch Gen Psychiatry. 1996 Jul;53(7):574–576. doi: 10.1001/archpsyc.1996.01830070016004. [DOI] [PubMed] [Google Scholar]
  12. McGuffin P., Martin N. Science, medicine, and the future. Behaviour and genes. BMJ. 1999 Jul 3;319(7201):37–40. doi: 10.1136/bmj.319.7201.37. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Murray C. J., Lopez A. D. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet. 1997 May 24;349(9064):1498–1504. doi: 10.1016/S0140-6736(96)07492-2. [DOI] [PubMed] [Google Scholar]
  14. Omran A. R. The epidemiologic transition. A theory of the epidemiology of population change. Milbank Mem Fund Q. 1971 Oct;49(4):509–538. [PubMed] [Google Scholar]
  15. Spigset O., Mårtensson B. Fortnightly review: drug treatment of depression. BMJ. 1999 May 1;318(7192):1188–1191. doi: 10.1136/bmj.318.7192.1188. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Von Korff M., Katon W., Bush T., Lin E. H., Simon G. E., Saunders K., Ludman E., Walker E., Unutzer J. Treatment costs, cost offset, and cost-effectiveness of collaborative management of depression. Psychosom Med. 1998 Mar-Apr;60(2):143–149. doi: 10.1097/00006842-199803000-00005. [DOI] [PubMed] [Google Scholar]
  17. Wells K. B. The design of Partners in Care: evaluating the cost-effectiveness of improving care for depression in primary care. Soc Psychiatry Psychiatr Epidemiol. 1999 Jan;34(1):20–29. doi: 10.1007/s001270050107. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Public Health are provided here courtesy of American Public Health Association

RESOURCES